Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance

OBJECTIVES: Pancreatic carcinoma is one of the most aggressive cancers overcoming chemoresistance. Thus, novel compounds to complement the current antitumor agents are in need. Ocoxin oral solution (OOS) has proven antioxidant, anti-inflammatory, and antistromagenic properties. The aim of this study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pancreas
Autori principali: Hernandez-Unzueta, Iera, Benedicto, Aitor, Romayor, Irene, Herrero, Alba, Sanz, Eduardo, Arteta, Beatriz, Olaso, Elvira, Márquez, Joana
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493672/
https://ncbi.nlm.nih.gov/pubmed/30946238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000001277
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi